Chad Pecot Archives - UNC Lineberger

Chad Pecot, MD, and Kristina Whately, PhD, work in the Pecot Lab.

Chad Pecot, MD, leads cancer RNA research at UNC Lineberger, creating innovative therapies and promising treatment strategies for multiple cancer mutations.

Schematic of an EGFR targeting ligand, linked to a dual targeting KRAS and MYC chimera molecule.

Chad Pecot, MD, and colleagues have developed a “two-in-one” molecule that targets hard-to-treat cancers by silencing two key genes — KRAS and MYC — while also delivering drugs directly to affected tumors.

Single strand ribonucleic acid, RNA research and therapy.

Chad Pecot, MD, and colleagues have demonstrated that a uniquely engineered drug that zeroes in on a mutated gene called KRAS G12V could potentially stop KRAS-dependent cancers in their tracks.

Two cancer researchers in a lab holding a slide to view under a microscope.

The American Association of Cancer Research has designated May as National Cancer Research Month to help underscore the importance and impact of cancer research.

Chad Pecot in his research lab at UNC Lineberger Comprehensive Cancer Center.

Chad Pecot, MD, is revolutionizing RNA therapies for cancer through his company EnFuego Therapeutics and the new UNC RNA Discovery Center.

The UNC RNA Discovery Center held its inaugural retreat to bring together its members and trainees to present and discuss RNA science being conducted across UNC-Chapel Hill and beyond.

Exteriors of the UNC Lineberger and Marsico Hall buildings.

The UNC RNA Discovery Center has awarded three fellowship grants to support innovative research investigating various roles of RNA in health and disease.

The grant will support Chad Pecot, MD, and his research investigating the roles circular RNA may have in regulating whether a form of lung cancer will spread beyond the original cancer site.

Physician-scientist and cancer survivor Chad Pecot, MD, is focused on RNA discoveries in the lab and the clinic.

The grant supports Chad Pecot, MD, and his research into the mechanistic and therapeutic implications of co-targeting two genes linked to lung cancer.

Tag: Chad Pecot

‘If you’re trying to make a difference in cancer, you can’t go slow’

New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes

Uniquely engineered KRAS-targeted cancer drug found to be effective in early studies

UNC Lineberger commemorates National Cancer Research Month

Fired up for RNA

UNC RNA Discovery Center retreat further builds community, highlight possibilities

UNC RNA Discovery Center awards inaugural fellowship grants

NCI awards Pecot $1.8 million lung cancer research grant

RNA discoveries drive oncologist’s next chapter

Lung Cancer Initiative awards Pecot $100,000 grant